A Küpfer

4.1k total citations
63 papers, 3.2k citations indexed

About

A Küpfer is a scholar working on Pharmacology, Oncology and Clinical Biochemistry. According to data from OpenAlex, A Küpfer has authored 63 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 14 papers in Oncology and 14 papers in Clinical Biochemistry. Recurrent topics in A Küpfer's work include Pharmacogenetics and Drug Metabolism (24 papers), Metabolism and Genetic Disorders (14 papers) and Chemotherapy-induced organ toxicity mitigation (10 papers). A Küpfer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (24 papers), Metabolism and Genetic Disorders (14 papers) and Chemotherapy-induced organ toxicity mitigation (10 papers). A Küpfer collaborates with scholars based in Switzerland, United States and Germany. A Küpfer's co-authors include R Preisig, J Bircher, Jeffrey R. Idle, Ai‐Ming Yu, Frank J. Gonzalez, Robert A. Branch, T. Cerny, B H Lauterburg, C. Aeschlimann and Kristopher W. Krausz and has published in prestigious journals such as The Lancet, Journal of Cell Science and British Journal of Cancer.

In The Last Decade

A Küpfer

63 papers receiving 3.1k citations

Peers

Countries citing papers authored by A Küpfer

Since Specialization

Citations

This map shows the geographic impact of A Küpfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Küpfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Küpfer more than expected).

Fields of papers citing papers by A Küpfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Küpfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Küpfer. The network helps show where A Küpfer may publish in the future.

Co-authorship network of co-authors of A Küpfer

This figure shows the co-authorship network connecting the top 25 collaborators of A Küpfer. A scholar is included among the top collaborators of A Küpfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Küpfer. A Küpfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Relative Contribution of Monoamine Oxidase and Cytochrome P450 Isozymes to the Metabolic Deamination of the Trace Amine Tryptamine 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Ai‐Ming Yu, Camille Granvil, Robert L. Haining, Kristopher W. Krausz, Javier Corchero, A Küpfer, Jeffrey R. Idle, Frank J. Gonzalez	43
2	Contribution of Individual Cytochrome P450 Isozymes to the O-Demethylation of the Psychotropic β-Carboline Alkaloids Harmaline and Harmine 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Ai‐Ming Yu, Jeffrey R. Idle, Kristopher W. Krausz, A Küpfer, Frank J. Gonzalez	99
3	Pharmacokinetics and organ distribution of intravenous and oral methylene blue 2000 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), A Küpfer, B H Lauterburg	308
4	Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients 1999 ·Annals of Oncology ·T. Cerny, Serge Leyvraz, Thomas von Briel, A Küpfer, (unknown), S.‐F. Hsu Schmitz, Paul Honegger, Cristiana Sessa, Janet Brunner, Alan V. Boddy	30
5	Increased urinary losses of carnitine during ifosfamide chemotherapy 1999 ·Cancer Chemotherapy and Pharmacology ·(unknown), Theresa Visarius, A Küpfer, Bernhard H. Lauterburg	26
6	Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy 1996 ·European Journal of Clinical Pharmacology ·A Küpfer, C. Aeschlimann, T. Cerny	86
7	Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue 1994 ·The Lancet ·A Küpfer, C. Aeschlimann, (unknown), T. Cerny	132
8	Depletion of circulating cyst(e)ine by oral and intravenous mesna 1993 ·British Journal of Cancer ·(unknown), T. Cerny, A Küpfer, (unknown), B H Lauterburg	26
9	Metabolism and pharmacokinetics of oral and intravenous ifosfamide 1991 ·Journal of Cancer Research and Clinical Oncology ·Volkhard Kurowski, T. Cerny, A Küpfer, Thomas Wagner	39
10	Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility 1991 ·Journal of Cancer Research and Clinical Oncology ·T. Cerny, A. Graf, (unknown), Tanja Zeugin, (unknown), A Küpfer	5
11	Identification of the “major” polymorphic carbocysteine metabolite as S-(carboxymethylthio)-l-cysteine 1991 ·Biochemical Pharmacology ·Claus O. Méese, Christine Fischer, A Küpfer, Hermann Wisser, Michel Eichelbaum	15
12	Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study 1991 ·Journal of Cancer Research and Clinical Oncology ·T. Cerny, Giovanni Martinelli, Aron Goldhirsch, F. Terrier, R Joss, Martin F. Fey, (unknown), A Küpfer	20
13	Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylator phenotype? 1990 ·British Journal of Pharmacology ·M Pirovino, Ulrich E. Honegger, Otfried Müller, (unknown), A Küpfer, Marina Tinel, Dominique Pessayre	6
14	In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat 1988 ·Biochemical Pharmacology ·Thomas Zysset, Tanja Zeugin, A Küpfer	42
15	Importance of Oxidative Polymorphism on Clinical Efficacy and Side-Effects of Imipramine - A Retrospective Study 1988 ·Pharmacopsychiatry ·Jörg Meyer, B. Woggon, A Küpfer	15
16	Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Wolfgang Lindner, Ivar Roots, B. M. Frey, A Küpfer	58
17	Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation 1985 ·Clinical Pharmacology & Therapeutics ·A Küpfer, Robert A. Branch	74
18	The differential localization of various drug metabolizing systems within the rat liver lobule as determined by the hepatotoxins allyl alcohol, carbon tetrachloride and bromobenzene. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·Richard James, Paul Desmond, A Küpfer, S. Schenker, Robert A. Branch	47
19	Stereoselectivity of differential routes of drug metabolism: the fate of the enantiomers of [14C]mephenytoin in the dog. 1979 ·Journal of Pharmacology and Experimental Therapeutics ·A Küpfer, J Bircher	27
20	Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog. 1977 ·Journal of Pharmacology and Experimental Therapeutics ·A Küpfer, J Bircher, R Preisig	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact